Boston Scientific Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2007 | $934.0M | $571.0M | $363.0M | $122.0M |
| FY2008 | $1.22B | $854.0M | $362.0M | $138.0M |
| FY2009 | $835.0M | $523.0M | $312.0M | $144.0M |
| FY2010 | $325.0M | $53.0M | $272.0M | $150.0M |
| FY2011 | $1.01B | $704.0M | $304.0M | $128.0M |
| FY2012 | $1.28B | $1.05B | $226.0M | $108.0M |
| FY2013 | $1.11B | $865.0M | $245.0M | $105.0M |
| FY2014 | $1.27B | $1.01B | $259.0M | $103.0M |
| FY2015 | $691.0M | $444.0M | $247.0M | $107.0M |
| FY2016 | $1.18B | $806.0M | $376.0M | $116.0M |
| FY2017 | $1.43B | $1.11B | $319.0M | $127.0M |
| FY2018 | $310.0M | $-6.0M | $316.0M | $140.0M |
| FY2019 | $1.84B | $1.38B | $461.0M | $157.0M |
| FY2020 | $1.51B | $1.13B | $376.0M | $170.0M |
| FY2021 | $1.87B | $1.32B | $554.0M | $194.0M |
| FY2022 | $1.53B | $938.0M | $588.0M | $220.0M |
| FY2023 | $2.50B | $1.79B | $711.0M | $233.0M |
| FY2024 | $3.44B | $2.65B | $790.0M | $266.0M |
| FY2025 | $4.53B | $3.66B | $876.0M | $299.0M |